Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

about

Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

P2860

Q55349380-A62E79B3-D48C-4C60-99C1-FA6536B634A5

P2860

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Item

http://www.wikidata.org/entity/Q52580522

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Evaluation of the fusion inhib ...... ent HIV transmission in women.

@en

Evaluation of the fusion inhib ...... ent HIV transmission in women.

@nl

type

Item

label

Evaluation of the fusion inhib ...... ent HIV transmission in women.

@en

Evaluation of the fusion inhib ...... ent HIV transmission in women.

@nl

prefLabel

Evaluation of the fusion inhib ...... ent HIV transmission in women.

@en

Evaluation of the fusion inhib ...... ent HIV transmission in women.

@nl

P1476

Evaluation of the fusion inhib ...... ent HIV transmission in women.

@en

P2093

Ana Rita Diniz

http://www.w3.org/2001/XMLSchema#string

Carlos Cardoso

http://www.w3.org/2001/XMLSchema#string

João Pedro Ferreira

http://www.w3.org/2001/XMLSchema#string

Maria Angel Muñoz-Fernández

http://www.w3.org/2001/XMLSchema#string

Maria Rosário Bronze

http://www.w3.org/2001/XMLSchema#string

Pilar Garcia Broncano

http://www.w3.org/2001/XMLSchema#string

Rafael Ceña Diaz

http://www.w3.org/2001/XMLSchema#string

P2860

Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

An algorithm for the preclinical development of anti-HIV topical microbicides.

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

A vaginal fluid simulant.

Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety

Indigogenic substrates for detection and localization of enzymes.

Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety.

P304

e0195744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0195744

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29668740

http://www.w3.org/2001/XMLSchema#string

P932

5905968

http://www.w3.org/2001/XMLSchema#string

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

about

P2860

P2860

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932